Skip to Main Content

Author Details

Clare Verrill
NIHR Oxford Biomedical Research Centre
2002
84
27
PMIDPaper TitleJournal TitlePublished Year
35906044Impact of the transition to digital pathology in a clinical setting on histopathologists in training: experiences and perceived challenges within a UK training region.J Clin Pathol2023
37628903Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.Int J Mol Sci2023
37443538Department Wide Validation in Digital Pathology-Experience from an Academic Teaching Hospital Using the UK Royal College of Pathologists' Guidance.Diagnostics (Basel)2023
36695816Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique.BJU Int2023
36831506Clinical Significance of Tumour-Infiltrating B Lymphocytes (TIL-Bs) in Breast Cancer: A Systematic Literature Review.Cancers (Basel)2023
34796679Understanding the ethical and legal considerations of Digital Pathology.J Pathol Clin Res2022
35551217Lessons from a breast cell annotation competition series for school pupils.Sci Rep2022
35626380The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.Diagnostics (Basel)2022
36085678A Graph Based Neural Network Approach to Immune Profiling of Multiplexed Tissue Samples.Annu Int Conf IEEE Eng Med Biol Soc2022
35979219RFID analysis of the complexity of cellular pathology workflow-An opportunity for digital pathology.Front Med (Lausanne)2022
35322056Automated quality assessment of large digitised histology cohorts by artificial intelligence.Sci Rep2022
32616541Role of digital pathology in diagnostic histopathology in the response to COVID-19: results from a survey of experience in a UK tertiary referral hospital.J Clin Pathol2021
35474657Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.BJUI Compass2021
33678516Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.Eur J Cancer2021
33809521The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer.Cancers (Basel)2021
34488682Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis.BMC Cancer2021
34419085WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.Diagn Pathol2021
34017063Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies.Mod Pathol2021
33125710IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans.Eur J Immunol2021
32620678Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.J Clin Pathol2021
31557341Tumour seeding of the renal tumour biopsy tract - a histologically under-recognised feature?Histopathology2020
32030460Correction to: Development of a new reproductive tissue cryopreservation clinical service for children: the Oxford programme.Pediatr Surg Int2020
31771983Self-Maintaining CD103<sup>+</sup> Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.Cancer Immunol Res2020
32591433Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial.J Immunother Cancer2020
32477618Guidance for Remote Reporting of Digital Pathology Slides During Periods of Exceptional Service Pressure: An Emergency Response from the UK Royal College of Pathologists.J Pathol Inform2020
32229180Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration.J Mol Diagn2020
30275096Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute's Cellular Molecular Pathology (CM-Path) initiative.J Clin Pathol2019
31897354On the Edge of a Digital Pathology Transformation: Views from a Cellular Pathology Laboratory Focus Group.J Pathol Inform2019
31213473Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8<sup>+</sup> Tumor-Infiltrating T Lymphocyte Responses.Cancer Immunol Res2019
31267143Development of a new reproductive tissue cryopreservation clinical service for children: the Oxford programme.Pediatr Surg Int2019
31575975CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom.Br J Cancer2019
31510810Tumor heterogeneity: does it matter?Expert Rev Anticancer Ther2019
30767396The use of digital pathology and image analysis in clinical trials.J Pathol Clin Res2019
31144302Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice.J Pathol2019
30680942Training and accreditation standards for pathologists undertaking clinical trial work.J Pathol Clin Res2019
30266332Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.J Urol2019
30518631Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.J Clin Pathol2019
30591353Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre.Eur Urol2019
30407751Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work.J Pathol Clin Res2019
29339090Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.Am J Pathol2018
30264692Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.Health Technol Assess2018
30449733An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.Cancer Res2018
29645347Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?BJU Int2018
29388947Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.Genet Med2018
29579010Intraoperative Consultation and Macroscopic Handling: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.Am J Surg Pathol2018
29467373Deep learning based tissue analysis predicts outcome in colorectal cancer.Sci Rep2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29566999Bilateral Testicular Germ Cell Tumors: A Case-Series From a UK-Based Tertiary Referral Center Over 19 Years.Clin Genitourin Cancer2018
29735545Nuclear IGF1R Interacts with Regulatory Regions of Chromatin to Promote RNA Polymerase II Recruitment and Gene Expression Associated with Advanced Tumor Stage.Cancer Res2018
29336917Changing Practice Evaluation-Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols-Experience From a Supraregional Center.Clin Genitourin Cancer2018
  • 1 - 50 of 84

Recommended Authors

Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Neil Mendhiratta
National Cancer Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 2
Susan Prendeville
University of Toronto
Career Start Year 2013
Number of shared co-authors 5
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Career Start Year 2013
Number of shared co-authors 0
Dibson D Gondim
University of Louisville
Career Start Year 2012
Number of shared co-authors 1
Simpa S Salami
University of Michigan Medical School ann arbor
Career Start Year 2012
Number of shared co-authors 1
Yee Wah Tsang
University Hospitals Coventry and Warwickshire National Health Service Trust
Career Start Year 2010
Number of shared co-authors 2
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 8
Jeffrey J Tosoian
Vanderbilt University Medical Center
Career Start Year 2008
Number of shared co-authors 2
Fadi Brimo
McGill University Health Centre, McGill University
Career Start Year 2007
Number of shared co-authors 9
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 0
Michelle R Downes
University of Toronto
Career Start Year 2006
Number of shared co-authors 5
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 3
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2002
Number of shared co-authors 10
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 0
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 9
Willem Vreuls
Canisius Wilhelmina Hospital
Career Start Year 2000
Number of shared co-authors 0
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 11
Todd M Morgan
University of Michigan ann arbor
Career Start Year 1997
Number of shared co-authors 9
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Career Start Year 1996
Number of shared co-authors 9
Sahussapont J Sirintrapun
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 4
David Clouston
Career Start Year 1995
Number of shared co-authors 10
Jeroen A W M van der Laak
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 4
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 6
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 8
Michael J Becich
University of Pittsburgh School of Medicine
Career Start Year 1982
Number of shared co-authors 1
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 7
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 9
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 23

Collaborators

Freddie C Hamdy
University of Oxford
Co-authored papers 18
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 7
Alastair D Lamb
University of Oxford
Co-authored papers 6
Korsuk Sirinukunwattana
Institute of Biomedical Engineering (IBME), University of Oxford
Co-authored papers 5
Adam Lambert
University of Oxford
Co-authored papers 4
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 4
Lars Egevad
Karolinska Institute
Co-authored papers 4
Pelvender Gill
University of Oxford
Co-authored papers 4
Luke Marsden
University of Oxford
Co-authored papers 3
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Co-authored papers 3
Francesca M Buffa
University of Oxford
Co-authored papers 3
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 3
John R Srigley
University of Toronto
Co-authored papers 3
Ian G Mills
Queen's University Belfast
Co-authored papers 3
Barbara Kremeyer
University College London
Co-authored papers 2
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 2
Peter A Humphrey
Yale University School of Medicine
Co-authored papers 2
Nening Dennis
Institute of Cancer Research
Co-authored papers 2
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 2
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Charlie E Massie
University of Cambridge
Co-authored papers 2
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 2
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 2
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 2
David Jones
Wellcome Sanger Institute
Co-authored papers 2
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 2
Hayley C Whitaker
University College London
Co-authored papers 2
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 2
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 2
Hayley J Luxton
University College London
Co-authored papers 2
Release 1.2